Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ARCTURUS THERAPEUTICS HOLDINGS INC.

(ARCT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Sector Update: Health Care Stocks Advancing Tuesday

08/03/2021 | 01:43pm EDT


ę MT Newswires 2021
All news about ARCTURUS THERAPEUTICS HOLDINGS INC.
09/15INDONESIA IN TALKS WITH WHO TO BECOM : minister
RE
09/08ARCTURUS THERAPEUTICS : to Participate in Citi's 16th Annual BioPharma Virtual C..
BU
09/07ARCTURUS THERAPEUTICS : to Present at Upcoming Investor and Scientific Conferenc..
BU
08/26ARCTURUS THERAPEUTICS HOLDINGS INC. : Termination of a Material Definitive Agree..
AQ
08/26Arcturus Therapeutics Holdings Inc. Announces the Resignation of Karah Parsch..
CI
08/25ARCTURUS THERAPEUTICS : Citigroup Adjusts Price Target on Arcturus Therapeutics ..
MT
08/13NORTH AMERICAN MORNING BRIEFING : Blockbuster -3-
DJ
08/12NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
08/12ARCTURUS THERAPEUTICS : Raymond James Downgrades Arcturus Therapeutics Holdings ..
MT
08/11ARCTURUS THERAPEUTICS : Shares Fall After Goldman Sachs Downgrade
MT
More news
Analyst Recommendations on ARCTURUS THERAPEUTICS HOLDINGS INC.
More recommendations
Financials (USD)
Sales 2021 66,8 M - -
Net income 2021 -168 M - -
Net cash 2021 278 M - -
P/E ratio 2021 -8,88x
Yield 2021 -
Capitalization 1 434 M 1 434 M -
EV / Sales 2021 17,3x
EV / Sales 2022 2,78x
Nbr of Employees 118
Free-Float 85,1%
Chart ARCTURUS THERAPEUTICS HOLDINGS INC.
Duration : Period :
Arcturus Therapeutics Holdings Inc. Technical Analysis Chart | ARCT | US03969T1097 | MarketScreener
Technical analysis trends ARCTURUS THERAPEUTICS HOLDINGS INC.
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 14
Last Close Price 54,45 $
Average target price 78,46 $
Spread / Average Target 44,1%
EPS Revisions
Managers and Directors
Joseph E. Payne President, Chief Executive Officer & Director
Andrew H. Sassine Chief Financial Officer & Director
Peter C. Farrell Chairman
Padmanabh Chivukula Secretary, Chief Operating & Scientific Officer
Steven G. Hughes Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
ARCTURUS THERAPEUTICS HOLDINGS INC.25.52%1 434
MODERNA, INC.311.65%173 588
LONZA GROUP AG32.35%60 074
IQVIA HOLDINGS INC.43.07%49 116
CELLTRION, INC.-23.26%31 904
SEAGEN INC.-10.81%28 420